VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.

Department of Health and Human Services

Award: Department of Health and Human ServicesNAICS n/aSAM# 75A50123C00050

Posted 2026-07-19 · Response deadline 2027-12-31 · Set-aside: None

Recipient: BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL | $39762216.0

View official SAM.gov notice →

← All opportunities